Supplier News

Evonik will acquire Transferra for an undisclosed amount, and the transaction is scheduled to close at the end of July 2016

MilliporeSigma and the International Vaccine Institute in Seoul, South Korea aim to develop more robust, scalable vaccine manufacturing processes.

The facility will be built in approximately 18 months using GE Healthcare’s KUBio modular facility solution.

Charles River acquired Blue Stream Laboratories, an analytical contract research organization.

A new facility in Marlborough, MA, will house laboratories to support GE Healthcare Life Sciences’ biomanufacturing and development operations.

Thermo will provide access to its instruments to NIBRT so that the Dublin-based group can generate helpful characterization data.

The ambr 250 is a mini bioreactor system for parallel fermentation or cell culture.

Lonza will continue to sponsor the conservation of horseshoe crabs, which are used in endotoxin testing.

Brammer Bio establishes late-phase development and commercial manufacturing facility for advanced cell and gene therapies in Lexington, MA.

The vaccine alternative, manufactured with a GE FlexFactory system, could be associated with fewer adverse reactions than the live vaccine option

The wearable devices for the delivery of biologic products are now being manufactured and will be tested in clinical trials in the near future, according to the company.

The collaboration will provide GMP manufacturing ahead of future clinical studies.

The company opened a 200,000-square-foot facility in Kakegawa, Japan to serve the needs of domestic and global clinical trial sponsors.

The company plans to introduce HDX–MS in quarter three of 2016 at its West Chester, PA facility.

The company showcased new technologies at ASMS for biopharmaceutical characterization.

Production of kilogram-scale batches of synthetic molecules for early-stage development are now available to US customers.

The company opened a new sales office located in Seoul, South Korea.

The company opened its 62,000 square foot facility, called the BioProcess Innovation Center, in Triangle Park, NC.

The companies have launched VEGF 165, their first joint product for cell culture applications.

The company’s method reduces the time required to crystallize antibodies from weeks to one day.

The awards were presented at the AAPS Biotechnology Conference and included awards for ligand binding, innovation in biotechnology, and graduate student symposiums.

Pelican BioThermal, a provider of temperature-controlled packaging solutions for the life-sciences industry, announced on May 13, 2016 that it has entered into partnerships with BioThermal Solutions and NatBio, which offer cold chain logistics support in South America. Located in Sao Paulo, Brazil, NatBio was created to meet the demands of specialized clinics. BioThermal Solutions, based in Santiago, Chile, provides cold-chain maintenance solutions throughout Chile.

FUJIFILM Diosynth Biotechnologies Opens New Laboratory Facility in Research Triangle Park, NC.

Typical single-use bags and materials cannot withstand a large range of temperatures. Many of the items on the market are associated with extractables that can leach into bioprocessing fluids-an issue that has recently been a topic of conversation among groups that seek to standardize single-use systems, such as the BioPhorum Operations Group (BPOG) and the Bio-Process Systems Alliance (BPSA).

The companies have agreed to an all-stock merger of equals transaction anticipated to close in the second half of 2016.

The company announced the launch of its first-in-class Lynx CDR connectors at INTERPHEX 2016.

Plasticell was recognized for its contribution to the advancement of regenerative medicine, cell and gene therapy, as well as other areas of biomedical research.

Pfizer announced the launch of Pfizer CentreOne, a CMO formed by the combination of Pfizer CentreSource and Hospira One 2 One.

Extract Technology’s portfolio will now include aseptic solutions, containment solutions, restricted access barriers, and mobile cleanrooms for the pharmaceutical, healthcare, biotech and chemical markets.

Through two acquisitions, Recipharm will acquire Kemwell’s United States, Swedish, and Indian operations.